NCT02706652View on ClinicalTrials.gov

Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients

Enrolling by invitationOBSERVATIONAL

Enrollment

900

Participants

Timeline

Start Date

May 22, 2018

Primary Completion Date

December 1, 2026

Study Completion Date

December 1, 2026

Conditions

Cancer

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH